{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:26:44Z","timestamp":1784042804058,"version":"3.55.0"},"reference-count":57,"publisher":"Cambridge University Press (CUP)","issue":"7","license":[{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Psychol. Med."],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S0033291721005146_sec_a1\"><jats:title>Background<\/jats:title><jats:p>To offer support for patients who decide to discontinue antipsychotic and antidepressant medication, identifying which potentially modifiable factors correlate with discontinuation success is crucial. Here, we analyzed the predictive value of the professional support received, circumstances prior to discontinuation, a strategy of discontinuation, and use of functional and non-functional coping strategies during discontinuation on self-reported discontinuation success and on objective discontinuation.<\/jats:p><\/jats:sec><jats:sec id=\"S0033291721005146_sec_a2\" sec-type=\"methods\"><jats:title>Methods<\/jats:title><jats:p>Patients who had attempted discontinuing antipsychotics (AP) and\/or antidepressants (AD) during the past 5 years (<jats:italic>n<\/jats:italic> = 316) completed an online survey including questions on subjective and objective discontinuation success, sociodemographic, clinical and medication-related factors, and scales to assess the putative predictors.<\/jats:p><\/jats:sec><jats:sec id=\"S0033291721005146_sec_a3\" sec-type=\"results\"><jats:title>Results<\/jats:title><jats:p>A regression model with all significant predictors explained 20\u201330% of the variance in discontinuation success for AD and 30\u201340% for AP. After controlling for baseline sociodemographic, clinical and medication-related factors, the most consistent predictor of subjective discontinuation success was self-care behavior, in particular mindfulness, relaxation and making use of supportive relationships. Other predictors depended on the type of medication: For AD, good alliance with the prescribing physician predicted higher subjective success whereas gradual tapering <jats:italic>per se<\/jats:italic> was associated with lower subjective success and a lower chance of full discontinuation. In those tapering off AP, leaving time to adjust between dose reductions was associated with higher subjective success and fewer negative effects.<\/jats:p><\/jats:sec><jats:sec id=\"S0033291721005146_sec_a4\" sec-type=\"conclusions\"><jats:title>Conclusions<\/jats:title><jats:p>The findings can inform evidence-based clinical guidelines and interventions aiming to support patients during discontinuation. Further studies powered to take interactions between variables into account are needed to improve the prediction of successful discontinuation.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s0033291721005146","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T08:16:40Z","timestamp":1640247400000},"page":"3085-3095","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":8,"title":["Predictors of successful discontinuation of antipsychotics and antidepressants"],"prefix":"10.1017","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6674-2440","authenticated-orcid":false,"given":"Tania M.","family":"Lincoln","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Quazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Witzgall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Schlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"S0033291721005146_ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2021.113768"},{"key":"S0033291721005146_ref14","doi-asserted-by":"publisher","DOI":"10.6101\/AZQ\/000366"},{"key":"S0033291721005146_ref31","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2016.0076"},{"key":"S0033291721005146_ref56","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-019-0989-5"},{"key":"S0033291721005146_ref12","first-page":"l2238","article-title":"Clinical guidelines on antidepressant withdrawal urgently need updating","volume":"365","author":"Davies","year":"2019","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"S0033291721005146_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30032-X"},{"key":"S0033291721005146_ref23","volume-title":"Guidance for psychological therapists: Enabling conversations with clients taking or withdrawing from prescribed psychiatric drugs.","author":"Guy","year":"2019"},{"key":"S0033291721005146_ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s00127-016-1306-4"},{"key":"S0033291721005146_ref36","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2315"},{"key":"S0033291721005146_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12599-8"},{"key":"S0033291721005146_ref1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2010.09060880"},{"key":"S0033291721005146_ref11","unstructured":"Darton, K. (2016). How to: Coming off psychiatric drugs. https:\/\/www.mind.org.uk\/media\/4727659\/coming-off-psychiatric-drugs-2016-pdf.pdf."},{"key":"S0033291721005146_ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032312"},{"key":"S0033291721005146_ref43","unstructured":"NICE. (2009b). Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care. NICE clinical guideline 82. Available at http:\/\/www.nice.org.uk\/CG82."},{"key":"S0033291721005146_ref53","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000959"},{"key":"S0033291721005146_ref40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001861"},{"key":"S0033291721005146_ref32","unstructured":"Lehmann, P. (Hrsg.). (2013). Psychopharmaka absetzen: Erfolgreiches Absetzen von Neuroleptika, Antidepressiva, Phasenprophylaktika, Ritalin und Tranquilizern (4. Aufl.). Lehmann, Peter."},{"key":"S0033291721005146_ref26","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbab017"},{"key":"S0033291721005146_ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000362317"},{"key":"S0033291721005146_ref49","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201400021"},{"key":"S0033291721005146_ref22","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320967183"},{"key":"S0033291721005146_ref33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60239-6"},{"key":"S0033291721005146_ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-039053"},{"key":"S0033291721005146_ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.569912"},{"key":"S0033291721005146_ref47","doi-asserted-by":"publisher","DOI":"10.1027\/1614-2241\/a000051"},{"key":"S0033291721005146_ref15","unstructured":"DGPPN (Hrsg.). (2019). S3-Leitlinie Schizophrenie\u2014Langfassung. Version 1.0, zuletzt ge\u00e4ndert am 15. M\u00e4rz 2019. https:\/\/www.awmf.org\/leitlinien\/detail\/ll\/038-009.html."},{"key":"S0033291721005146_ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2020.11.057"},{"key":"S0033291721005146_ref55","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1997.01830130055011"},{"key":"S0033291721005146_ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000370338"},{"key":"S0033291721005146_ref35","first-page":"260","article-title":"The revised helping alliance questionnaire (HAQ-II): Psychometric properties","volume":"5","author":"Luborsky","year":"1996","journal-title":"The Journal of Psychotherapy Practice and Research"},{"key":"S0033291721005146_ref13","unstructured":"Deutsche Gesellschaft f\u00fcr Soziale Psychiatrie. (2014). Neuroleptika reduzieren und absetzen. Eine Brosch\u00fcre f\u00fcr Psychose-Erfahrene, Angeh\u00f6rige und Professionelle aller Berufsgruppen. https:\/\/www.dgsp-ev.de\/fileadmin\/user_files\/dgsp\/pdfs\/Flyer_Infoblatt_KuFo-Programme_Broschueren\/ReduktionNeuroleptika_2014_web.pdf."},{"key":"S0033291721005146_ref38","doi-asserted-by":"publisher","DOI":"10.1159\/000477940"},{"key":"S0033291721005146_ref2","first-page":"23","article-title":"Der \u201chelping alliance questionnaire\u201d (HAQ) von Luborsky","volume":"40","author":"Bassler","year":"1995","journal-title":"Psychotherapeut"},{"key":"S0033291721005146_ref5","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291716002580"},{"key":"S0033291721005146_ref51","first-page":"46","article-title":"PEF-FB-9 \u2013 fragebogen zur partizipativen entscheidungsfindung (revidierte 9-item-fassung)","volume":"4","author":"Scholl","year":"2011","journal-title":"Klin Diagn Eval"},{"key":"S0033291721005146_ref20","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320954609"},{"key":"S0033291721005146_ref57","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00551"},{"key":"S0033291721005146_ref17","doi-asserted-by":"publisher","DOI":"10.1177\/2045125321991274"},{"key":"S0033291721005146_ref30","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000100"},{"key":"S0033291721005146_ref46","unstructured":"QuestBack GmbH. (2017). EFS Survey."},{"key":"S0033291721005146_ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12671-017-0759-1"},{"key":"S0033291721005146_ref44","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201700070"},{"key":"S0033291721005146_ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j3927"},{"key":"S0033291721005146_ref48","doi-asserted-by":"publisher","DOI":"10.1111\/jpm.12178"},{"key":"S0033291721005146_ref29","doi-asserted-by":"publisher","DOI":"10.1186\/ISRCTN12417565"},{"key":"S0033291721005146_ref45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097463"},{"key":"S0033291721005146_ref54","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00797"},{"key":"S0033291721005146_ref24","unstructured":"Hall, W. (2012). Harm reduction guide to coming off psychiatric drugs. http:\/\/www.willhall.net\/files\/ComingOffPsychDrugsHarmReductGuide2Edonline.pdf."},{"key":"S0033291721005146_ref50","unstructured":"Satow, L. (2012). Stress- und Coping-Inventar (SCI): Test- und Skalendokumentation. https:\/\/www.drsatow.de\/tests\/stress-und-coping-inventar\/."},{"key":"S0033291721005146_ref41","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.116.182683"},{"key":"S0033291721005146_ref39","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2336"},{"key":"S0033291721005146_ref42","unstructured":"NICE. (2009a). Depression in adults: Recognition and management. NICE Guideline (CG90). https:\/\/www.nice.org.uk\/guidance\/cg90."},{"key":"S0033291721005146_ref25","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320921694"},{"key":"S0033291721005146_ref10","doi-asserted-by":"publisher","DOI":"10.1017\/S1352465810000512"},{"key":"S0033291721005146_ref19","doi-asserted-by":"publisher","DOI":"10.3109\/00048671003705441"},{"key":"S0033291721005146_ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000506868"},{"key":"S0033291721005146_ref21","volume-title":"Staying well after psychosis. A cognitive interpersonal approach to recovery and relapse prevention","author":"Gumley","year":"2006"}],"container-title":["Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0033291721005146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T11:07:37Z","timestamp":1711451257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291721005146\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0033291721005146"],"URL":"https:\/\/doi.org\/10.1017\/s0033291721005146","relation":{},"ISSN":["0033-2917","1469-8978"],"issn-type":[{"value":"0033-2917","type":"print"},{"value":"1469-8978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,23]]},"assertion":[{"value":"Copyright \u00a9 The Author(s), 2021. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}